March 14, 2018 - By Peter Erickson

The stock of VODIS PHARMACEUTICALS INC ORDINARY SHARE (OTCMKTS:VDQSF) registered a decrease of 91.89% in short interest. VDQSF’s total short interest was 900 shares in March as published by FINRA. Its down 91.89% from 11,100 shares, reported previously. With 4,500 shares average volume, it will take short sellers 0 days to cover their VDQSF’s short positions. The short interest to VODIS PHARMACEUTICALS INC ORDINARY SHARE’s float is 0.01%.

The stock decreased 6.40% or $0.004 during the last trading session, reaching $0.299. About 550 shares traded or Infinity% up from the average. Vodis Pharmaceuticals Inc. (OTCMKTS:VDQSF) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Vodis Pharmaceuticals Inc. operates as an application stage firm for producing medical marijuana. The company has market cap of $11.49 million. It operates in Canada and the United States. It currently has negative earnings.

More notable recent Vodis Pharmaceuticals Inc. (OTCMKTS:VDQSF) news were published by: which released: “10 Top Canadian Cannabis Stocks” on October 20, 2016, also with their article: “Emblem Pharmaceuticals to Invest Significant Capital to Expand Production” published on October 17, 2016, published: “Hydropothecary Announces Results of Shareholders Meeting” on January 18, 2018. More interesting news about Vodis Pharmaceuticals Inc. (OTCMKTS:VDQSF) were released by: and their article: “Agritek Holdings, Inc. Announces Plans For Additional Cultivation Property …” published on February 23, 2017 as well as‘s news article titled: “MYM Nutraceuticals Releases Video on its Global Operations” with publication date: February 08, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: